Brief: Visen Pharmaceuticals Posts Loss For Year Of RMB253.4 Million
12/03/2026 15:04
March 12 (Reuters) - Visen Pharmaceuticals 2561.HK: LOSS FOR YEAR RMB253.4 MILLION Further company coverage: 2561.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Visen Pharmaceuticals
See all newsBrief: Visen Pharmaceuticals Posts Loss For Year Of RMB253.4 Million
Brief: Visen Pharmaceuticals Says NMPA Approves Lonapegsomatropin (Skytrofa) For Injection
Brief: Visen Pharmaceuticals Appoints Lu Ying As CFO
Brief: Visen Pharmaceuticals Logs HY Loss RMB118 Mln
Brief: Visen Pharmaceuticals Says Number Of Offer Shares Under Global Offering 11.4 Million